These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2885931)

  • 1. Ophthalmic beta-blockers since timolol.
    Novack GD
    Surv Ophthalmol; 1987; 31(5):307-27. PubMed ID: 2885931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of systemic beta-blocker therapy on the efficacy and safety of topical brimonidine and timolol. Brimonidine Study Groups 1 and 2.
    Schuman JS
    Ophthalmology; 2000 Jun; 107(6):1171-7. PubMed ID: 10857839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mode of action, clinical profile and significance of beta-blockers in antiglaucoma therapy].
    Schlote T
    Klin Monbl Augenheilkd; 2013 Feb; 230(2):120-6. PubMed ID: 23430677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological therapy for glaucoma: a review.
    Hoyng PF; van Beek LM
    Drugs; 2000 Mar; 59(3):411-34. PubMed ID: 10776828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular beta-blockers in glaucoma management. Clinical pharmacological aspects.
    Brooks AM; Gillies WE
    Drugs Aging; 1992; 2(3):208-21. PubMed ID: 1351412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the ocular beta-blockers.
    Sorensen SJ; Abel SR
    Ann Pharmacother; 1996 Jan; 30(1):43-54. PubMed ID: 8773166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experiences with timolol in treatment of glaucoma (author's transl)].
    Bischoff P
    Klin Monbl Augenheilkd; 1978 Aug; 173(2):202-7. PubMed ID: 359904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Latanoprost : an update of its use in glaucoma and ocular hypertension.
    Perry CM; McGavin JK; Culy CR; Ibbotson T
    Drugs Aging; 2003; 20(8):597-630. PubMed ID: 12795627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of ophthalmic beta-blocking agents.
    Lesar TS
    Clin Pharm; 1987 Jun; 6(6):451-63. PubMed ID: 2891463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy and safety of substituting a twice-daily regimen of timolol with a single daily instillation of nonpreserved beta-blocker in patients with chronic glaucoma or ocular hypertension].
    Bron A; Chiambaretta F; Pouliquen P; Rigal D; Rouland JF
    J Fr Ophtalmol; 2003 Sep; 26(7):668-74. PubMed ID: 13130253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the medication used to achieve the target intraocular pressure in glaucoma therapy of relevance?--an exemplary analysis on the basis of two beta-blockers.
    Grieshaber MC; Flammer J
    Prog Retin Eye Res; 2010 Jan; 29(1):79-93. PubMed ID: 19733652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data.
    Nordmann JP; Mertz B; Yannoulis NC; Schwenninger C; Kapik B; Shams N;
    Am J Ophthalmol; 2002 Jan; 133(1):1-10. PubMed ID: 11755834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study.
    Krupin T; Liebmann JM; Greenfield DS; Ritch R; Gardiner S;
    Am J Ophthalmol; 2011 Apr; 151(4):671-81. PubMed ID: 21257146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential systemic effect of topically applied beta-blockers in glaucoma therapy.
    Taniguchi T; Kitazawa Y
    Curr Opin Ophthalmol; 1997 Apr; 8(2):55-8. PubMed ID: 10168358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 7 year prospective comparative study of three topical beta blockers in the management of primary open angle glaucoma.
    Watson PG; Barnett MF; Parker V; Haybittle J
    Br J Ophthalmol; 2001 Aug; 85(8):962-8. PubMed ID: 11466256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of dorzolamide and timolol in patients with pseudoexfoliation and glaucoma or ocular hypertension.
    Heijl A; Strahlman E; Sverrisson T; Brinchman-Hansen O; Puustjärvi T; Tipping R
    Ophthalmology; 1997 Jan; 104(1):137-42. PubMed ID: 9022118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The favorable effect of topical betaxolol and timolol on glaucomatous visual fields: a 2-year follow-up study.
    Vainio-Jylhä E; Vuori ML
    Graefes Arch Clin Exp Ophthalmol; 1999 Feb; 237(2):100-4. PubMed ID: 9987624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combination of oral and topical beta-blockers with additive effects on intraocular pressure.
    Ohrström A; Kättström O
    Acta Ophthalmol (Copenh); 1983 Dec; 61(6):1021-8. PubMed ID: 6140811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pressure or progression?
    Burnstein Y; Robin AL
    Arch Ophthalmol; 1999 Mar; 117(3):417-9. PubMed ID: 10088833
    [No Abstract]   [Full Text] [Related]  

  • 20. Timolol. A beta-adrenergic blocking agent for the treatment of glaucoma.
    Zimmerman TJ; Kaufman HE
    Arch Ophthalmol; 1977 Apr; 95(4):601-4. PubMed ID: 322648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.